GCI Research is a strategic consulting firm that helps companies establish partnerships. It introduced a new pathogen inactivation technology using shockwaves to destroy viruses and bacteria in blood and plasma without chemicals. The technology is FDA-approved and works by exploiting differences in cell structure to selectively rupture pathogen membranes through rapid pressure changes. GCI Research invites interested parties to learn more about how this technology could increase global blood and plasma supplies while reducing diseases like Hepatitis C.

1. A Brief Example of Strategic
Alliance and Partnerships
Development by
GCI Research, Inc.
WHO WE ARE, WHAT WE DO, AREAS OF EXPERTISE, PRINCIPAL

2. Introducing a New Concept in
Pathogen Inactivation
INTRODUCTION BY GCI RESEARCH, INC.
AUGUST 2015

3. What this brief presentation covers:
• GCI Research, Inc.
• Introduction of the concept
• Invitation to learn more

4. What we do We help firms identify and establish mutually-
beneficial strategic alliances and development
partnerships that meet the needs of the parties
involved.
Who we are GCI Research is a boutique strategic planning,
business development, and market research
consultancy.

5. Areas of GCI’s
Expertise and
Experience in
Healthcare
Areas of Expertise Product Areas 30+ Countries
Accountable care
Advertising effectiveness
Competitor analysis
Concept testing
Customer relations
Customer success
Group purchasing analysis
Hospital/group potential
analysis
Managed care
Market segmentation
analysis
Market share & trends
analysis
Media selection
New product development
& evaluation
Resource allocation
Results tracking
Search engine
optimization
Strategic planning
SWOT analysis
…among others
Adhesives
Anesthesiology
Angiography/ angioplasty
Blood pressure monitoring
Biopsies, cancer
detection/diagnosis
Cardiology
Chest drainage
Critical/intensive care
Electrocardiography
Electrosurgery
Infection control
Interventional radiology
Obstetrics/gynecology
Orthopedics
Pain management
Plastic surgery
Prostate management
Respiratory care
Temperature monitoring
Urology
Wound management
…among others
Argentina
Brazil
Canada
Caribbean
China
Denmark
England
France
Germany
Holland
Hong Kong
Indonesia
Israel
Italy
Japan
Korea
Malaysia
Mexico
Philippines
Russia
Ukraine
United States
…among others

6. Robert Dunford,
Principal
• Business development manager, marketing director and
senior analyst in five, market-share leading, Fortune-15
and smaller firms.
• DirectedVoice of the Customer and Customer Success
programs in the 37 business units of the $4 billion MPT
Division of the Fortune-15 McKesson Company.
• Directed business development, market research, and
marketing communications in the $400 million,Georgia-
based Corporate Group of C.R. Bard, Inc.
• Created and directed marketing research, corporate
planning, and business development functions of the $32
million NDM Division of Baxter International
• Fluent in Spanish, BA in Marketing, MBA from
the University of Utah's David Eccles School of Business.

7. Introduction of the Concept
WHAT IT IS, WHAT IT DOES, WHAT IT DOESN’T DO, HOW IT WORKS

8. What it is
This is a new, patented technology for destroying blood pathogens, sterilizing
blood and possibly plasma. It is FDA-approved for other medical applications.
What it Does
Without actually contacting the blood or plasma, this new concept delivers
pressure shockwaves to destroy blood pathogens. Applying this technology
could bring a significant increase in the supply of blood and plasma world-
wide and significantly reduce the impact of viruses such as Hep C.
What it Doesn’t Do
This non-invasive technology does not use chemicals or radioactive materials
and does not produce heat.
•

9. o Dimensional differences
among blood cells, bacteria
and viruses, which make the
thinner bacterium/virus
membrane easier to be
breached by shock waves.
o Structural differences that
cause membranes for
bacteria and viruses to be
harder, when compared to
very flexible membranes of
blood cells.
o High sensitivity to sudden
pressures changes (shock
waves) for bacteria
membranes that affects their
mechanotransduction.
How it Works
Focused shock waves cause selective destruction of bacterium and virus membranes through:

10. The characteristics of focused
shock waves include:
How it Works (cont.)
• Compressive pressure 1,000
times ultrasound magnitude
• Extremely rapid rise time
• Negative pressure causing
cavitation
• Transient sonoluminescence
• Transient/localized high
heat
• Total duration of 5 to 8 µs.
• Dosage (number of shocks,
energy setting and
frequency) is key for success

11. We InviteYou to Learn More
CONTACT INFORMATION

12. For more information contact:
Robert R. Dunford, Managing Director
GCI Research, Inc.
396 EagleTiff Dr.
Sugar Hill, GA 30518 U.S.A.
• Call us at 678-288-9612 (office), 770-624-6924 (cell)
• Write us at robdunford@gciresearch.com
• Learn more about what we do at www.gciresearch.com
• Read what others say at www.linkedin.com/in/robdunford